unilabs holding limited
unilabs holding limited Company Information
Company Number
06275676
Website
www.unilabs-ihs.co.ukRegistered Address
24-32 stephenson way, london, NW1 2HD
Industry
Other human health activities
Telephone
02072994490
Next Accounts Due
35 days late
Group Structure
View All
Shareholders
unilabs laboratoire d'analyses medicales 100%
unilabs holding limited Estimated Valuation
Pomanda estimates the enterprise value of UNILABS HOLDING LIMITED at £0 based on a Turnover of £0 and 0.52x industry multiple (adjusted for size and gross margin).
unilabs holding limited Estimated Valuation
Pomanda estimates the enterprise value of UNILABS HOLDING LIMITED at £0 based on an EBITDA of £0 and a 4.56x industry multiple (adjusted for size and gross margin).
unilabs holding limited Estimated Valuation
Pomanda estimates the enterprise value of UNILABS HOLDING LIMITED at £0 based on Net Assets of £-2.3m and 2.38x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Unilabs Holding Limited Overview
Unilabs Holding Limited is a live company located in london, NW1 2HD with a Companies House number of 06275676. It operates in the other human health activities sector, SIC Code 86900. Founded in June 2007, it's largest shareholder is unilabs laboratoire d'analyses medicales with a 100% stake. Unilabs Holding Limited is a established, unknown sized company, Pomanda has estimated its turnover at £0 with unknown growth in recent years.
Upgrade for unlimited company reports & a free credit check
Unilabs Holding Limited Health Check
There is insufficient data available to calculate a health check for Unilabs Holding Limited. Company Health Check FAQs
0 Strong
0 Regular
2 Weak
Size
There is insufficient data available for this Key Performance Indicator!
- - Unilabs Holding Limited
- - Industry AVG
Growth
There is insufficient data available for this Key Performance Indicator!
- Unilabs Holding Limited
- - Industry AVG
Production
There is insufficient data available for this Key Performance Indicator!
- - Unilabs Holding Limited
- - Industry AVG
Profitability
There is insufficient data available for this Key Performance Indicator!
- - Unilabs Holding Limited
- - Industry AVG
Employees
with 2 employees, this is below the industry average (20)
- - Unilabs Holding Limited
- - Industry AVG
Pay Structure
There is insufficient data available for this Key Performance Indicator!
- - Unilabs Holding Limited
- - Industry AVG
Efficiency
There is insufficient data available for this Key Performance Indicator!
- - Unilabs Holding Limited
- - Industry AVG
Debtor Days
There is insufficient data available for this Key Performance Indicator!
- - Unilabs Holding Limited
- - Industry AVG
Creditor Days
There is insufficient data available for this Key Performance Indicator!
- - Unilabs Holding Limited
- - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- - Unilabs Holding Limited
- - Industry AVG
Cash Balance
There is insufficient data available for this Key Performance Indicator!
- - Unilabs Holding Limited
- - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 141.6%, this is a higher level of debt than the average (26.7%)
- - Unilabs Holding Limited
- - Industry AVG
UNILABS HOLDING LIMITED financials
Unilabs Holding Limited's latest turnover from December 2022 is 0 and the company has net assets of -£2.3 million. According to their latest financial statements, Unilabs Holding Limited has 2 employees and maintains cash reserves of 0 as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 9,391,057 | 0 | 0 | 0 |
| Other Income Or Grants | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
| Cost Of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 5,199,204 | 0 | 0 | |||
| Gross Profit | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 4,191,853 | 0 | 0 | |||
| Admin Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3,486,560 | 0 | 0 | |||
| Operating Profit | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 705,293 | 0 | 0 | 0 |
| Interest Payable | 153,092 | 101,403 | 112,023 | 126,127 | 121,472 | 110,126 | 116,499 | 117,940 | 116,681 | 115,914 | 0 | 126,697 | 139,230 | 224,550 |
| Interest Receivable | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2,522 | 0 | 0 | 0 |
| Pre-Tax Profit | -153,092 | -101,403 | -112,023 | -126,127 | -121,472 | -110,126 | -116,499 | -117,940 | -116,681 | -115,914 | 707,815 | -126,697 | -139,230 | -224,550 |
| Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -157,623 | 0 | 0 | 0 |
| Profit After Tax | -153,092 | -101,403 | -112,023 | -126,127 | -121,472 | -110,126 | -116,499 | -117,940 | -116,681 | -115,914 | 550,192 | -126,697 | -139,230 | -224,550 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Retained Profit | -153,092 | -101,403 | -112,023 | -126,127 | -121,472 | -110,126 | -116,499 | -117,940 | -116,681 | -115,914 | 550,192 | -126,697 | -139,230 | -224,550 |
| Employee Costs | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3,371,547 | 0 | 0 | 0 |
| Number Of Employees | 2 | 2 | 3 | 3 | 3 | 5 | 4 | 3 | 4 | 54 | ||||
| EBITDA* | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 956,925 | 0 | 0 | 0 |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Tangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 222,661 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments & Other | 5,500,000 | 5,500,000 | 5,500,000 | 5,500,000 | 5,500,000 | 5,500,000 | 5,500,000 | 5,500,000 | 5,500,000 | 5,500,000 | 0 | 5,500,000 | 5,500,000 | 5,500,000 |
| Debtors (Due After 1 year) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Fixed Assets | 5,500,000 | 5,500,000 | 5,500,000 | 5,500,000 | 5,500,000 | 5,500,000 | 5,500,000 | 5,500,000 | 5,500,000 | 5,500,000 | 222,661 | 5,500,000 | 5,500,000 | 5,500,000 |
| Stock & work in progress | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 39,564 | 0 | 0 | 0 |
| Trade Debtors | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1,598,920 | 0 | 0 | 0 |
| Group Debtors | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2,249,364 | 0 | 0 | 0 |
| Misc Debtors | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 325,762 | 0 | 0 | 0 |
| Cash | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1,622,952 | 0 | 0 | 0 |
| misc current assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total current assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 5,836,562 | 0 | 0 | 0 |
| total assets | 5,500,000 | 5,500,000 | 5,500,000 | 5,500,000 | 5,500,000 | 5,500,000 | 5,500,000 | 5,500,000 | 5,500,000 | 5,500,000 | 6,059,223 | 5,500,000 | 5,500,000 | 5,500,000 |
| Bank overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Bank loan | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Trade Creditors | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 513,434 | 0 | 0 | 0 |
| Group/Directors Accounts | 0 | 7,634,965 | 7,533,562 | 7,421,539 | 7,295,412 | 7,173,940 | 7,063,814 | 6,947,315 | 6,829,375 | 6,712,694 | 0 | 6,467,765 | 6,341,068 | 2,200,000 |
| other short term finances | 7,788,057 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other current liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 972,462 | 0 | 0 | 701,838 |
| total current liabilities | 7,788,057 | 7,634,965 | 7,533,562 | 7,421,539 | 7,295,412 | 7,173,940 | 7,063,814 | 6,947,315 | 6,829,375 | 6,712,694 | 1,485,896 | 6,467,765 | 6,341,068 | 2,901,838 |
| loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3,300,000 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accruals and Deferred Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| provisions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total long term liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3,300,000 |
| total liabilities | 7,788,057 | 7,634,965 | 7,533,562 | 7,421,539 | 7,295,412 | 7,173,940 | 7,063,814 | 6,947,315 | 6,829,375 | 6,712,694 | 1,485,896 | 6,467,765 | 6,341,068 | 6,201,838 |
| net assets | -2,288,057 | -2,134,965 | -2,033,562 | -1,921,539 | -1,795,412 | -1,673,940 | -1,563,814 | -1,447,315 | -1,329,375 | -1,212,694 | 4,573,327 | -967,765 | -841,068 | -701,838 |
| total shareholders funds | -2,288,057 | -2,134,965 | -2,033,562 | -1,921,539 | -1,795,412 | -1,673,940 | -1,563,814 | -1,447,315 | -1,329,375 | -1,212,694 | 4,573,327 | -967,765 | -841,068 | -701,838 |
| Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||||||||
| Operating Profit | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 705,293 | 0 | 0 | 0 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 251,632 | 0 | 0 | 0 |
| Amortisation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -157,623 | 0 | 0 | 0 |
| Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -39,564 | 39,564 | 0 | 0 | 0 |
| Debtors | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -4,174,046 | 4,174,046 | 0 | 0 | 0 |
| Creditors | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -513,434 | 513,434 | 0 | 0 | 0 |
| Accruals and Deferred Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -972,462 | 972,462 | 0 | -701,838 | 701,838 |
| Deferred Taxes & Provisions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash flow from operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2,727,714 | -1,928,412 | 0 | -701,838 | 701,838 |
| Investing Activities | ||||||||||||||
| capital expenditure | ||||||||||||||
| Change in Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 5,500,000 | -5,500,000 | 0 | 0 | 5,500,000 |
| cash flow from investments | ||||||||||||||
| Financing Activities | ||||||||||||||
| Bank loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Group/Directors Accounts | -7,634,965 | 101,403 | 112,023 | 126,127 | 121,472 | 110,126 | 116,499 | 117,940 | 116,681 | 6,712,694 | -6,467,765 | 126,697 | 4,141,068 | 2,200,000 |
| Other Short Term Loans | 7,788,057 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long term loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -3,300,000 | 3,300,000 |
| Hire Purchase and Lease Commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other long term liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| share issue | ||||||||||||||
| interest | -153,092 | -101,403 | -112,023 | -126,127 | -121,472 | -110,126 | -116,499 | -117,940 | -116,681 | -115,914 | 2,522 | -126,697 | -139,230 | -224,550 |
| cash flow from financing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 926,673 | -1,474,343 | 0 | 701,838 | 4,798,162 |
| cash and cash equivalents | ||||||||||||||
| cash | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1,622,952 | 1,622,952 | 0 | 0 | 0 |
| overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| change in cash | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1,622,952 | 1,622,952 | 0 | 0 | 0 |
unilabs holding limited Credit Report and Business Information
Unilabs Holding Limited Competitor Analysis
Perform a competitor analysis for unilabs holding limited by selecting its closest rivals, whether from the HUMAN HEALTH AND SOCIAL WORK ACTIVITIES sector, other established companies, companies in NW1 area or any other competitors across 12 key performance metrics.
unilabs holding limited Ownership
UNILABS HOLDING LIMITED group structure
Unilabs Holding Limited has 2 subsidiary companies.
Ultimate parent company
CIDRA SARL
#0071120
UNILABS LABORATOIRE D'ANALYSES MEDICALES
#0004085
2 parents
UNILABS HOLDING LIMITED
06275676
2 subsidiaries
unilabs holding limited directors
Unilabs Holding Limited currently has 3 directors. The longest serving directors include Dr Rahul Chaudhary (Feb 2024) and Mr Dhilum Alacon (Feb 2024).
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Dr Rahul Chaudhary | England | 47 years | Feb 2024 | - | Director |
| Mr Dhilum Alacon | 47 years | Feb 2024 | - | Director | |
| Mr Robin Dargue | England | 57 years | Sep 2024 | - | Director |
P&L
December 2022turnover
0
0%
operating profit
0
0%
gross margin
0%
0%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
December 2022net assets
-2.3m
+0.07%
total assets
5.5m
0%
cash
0
0%
net assets
Total assets minus all liabilities
unilabs holding limited company details
company number
06275676
Type
Private limited with Share Capital
industry
86900 - Other human health activities
incorporation date
June 2007
age
17
incorporated
UK
ultimate parent company
accounts
Full Accounts
last accounts submitted
December 2022
previous names
independent histopathology holding limited (September 2008)
hackremco (no. 2505) limited (August 2007)
accountant
-
auditor
GKP (AMPTHILL) LIMITED
address
24-32 stephenson way, london, NW1 2HD
Bank
-
Legal Advisor
-
unilabs holding limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We found 1 charges/mortgages relating to unilabs holding limited. Currently there are 0 open charges and 1 have been satisfied in the past.
unilabs holding limited Companies House Filings - See Documents
| date | description | view/download |
|---|
